List of Treatments for Ovarian Cancer
Below is a listing of treatments and therapies for ovarian cancer. Click on one to read more information or connect with others currently using it.
Avastin (Bevacizumab)
Overview
Avastin is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat lung, colorectal, breast, and several other cancers. Avastin is sometimes prescribed off-label to treat ovarian… read more
Clinical Trials
Overview
Depending on several factors, you may be eligible to participate in clinical trials studying new treatments for ovarian cancer. Clinical trials are the only way new treatments for ovarian cancer can be tested.… read more
Exercise
Overview
Regular physical activity has been shown to benefit people with ovarian cancer in many ways. Exercise can improve quality of life during and after treatment. Being physically active helps reduce fatigue and… read more
Lynparza (Olaparib)
Overview
Lynparza is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat deleterious germline or somatic BRCA-mutated advanced ovarian cancer who are in complete or partial response to… read more
Nutrition
Overview
Everyone feels their best when they consistently eat a healthy, balanced diet. For people with ovarian cancer, good nutrition can help you recover from treatment, reduce treatment side effects, support bone… read more
Rozlytrek (Entrectinib)
Overview
Rozlytrek is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat cancerous tumors that have a neurotrophic tyrosine receptor kinase (NTRK) gene fusion without a known resistance… read more
Rubraca (Rucaparib)
Overview
Rubraca is a prescription drug approved by the U.S. Food and Drug Administration (FDA) for the maintenance treatment of adult patients with recurrent epithelial ovarian cancer who are in a complete or partial… read more
Vitrakvi (Larotrectinib)
Overview
Vitrakvi is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat solid tumors that have a neurotrophic receptor tyrosine kinase (NTRK) gene fusion without a known resistance… read more
Zejula (Niraparib)
Overview
Zejula is a prescription drug approved by the U.S. Food and Drug Administration (FDA) for the maintenance treatment of adults with advanced or recurrent epithelial ovarian cancer who are in a complete or… read more
